1. Serum adiponectin levels and enzyme markers of liver dysfunction in diabetic and non-diabetic Caribbean subjects
- Author
-
Robert W. Schwenk, Chidum E. Ezenwaka, Jürgen Eckel, M. Uhlig, and Risha Kalloo
- Subjects
Male ,Microbiology (medical) ,medicine.medical_specialty ,medicine.medical_treatment ,Clinical Biochemistry ,Immunology ,Type 2 diabetes ,Microbiology ,Insulin resistance ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Glycated Hemoglobin ,Adiponectin ,business.industry ,Liver Diseases ,Insulin ,Biochemistry (medical) ,Middle Aged ,medicine.disease ,Infectious Diseases ,Endocrinology ,Diabetes Mellitus, Type 2 ,Homeostatic model assessment ,Alkaline phosphatase ,Female ,Liver function ,Insulin Resistance ,business ,Biomarkers ,hormones, hormone substitutes, and hormone antagonists - Abstract
Low adiponectin levels are associated with elevated plasma alanine aminotransferase, a marker of reduced hepatic insulin sensitivity and a risk factor for type 2 diabetes. This study aims to determine the relationship between serum adiponectin level and alanine aminotransferase in diabetic and non-diabetic subjects. Fifty-six type 2 diabetic patients and 33 non-diabetic subjects participate in the study. Baseline plasma concentrations of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and glucose are measured on a chemistry analyser. Insulin and adiponectin are measured using enzyme-linked immunoassay techniques and insulin resistance is determined using the homeostatic model assessment method. Diabetic patients showed significantly lower levels of serum adiponectin than did the non-diabetic subjects, whereas levels of alanine aminotransferase and alkaline phosphatase were similar in both groups. While female non-diabetic subjects showed higher serum adiponectin levels than did female diabetic patients, alanine aminotransferase level did not differ (P>0.05). No significant relationship was seen between adiponectin and alanine aminotransferase in diabetic and non-diabetic subjects (P>0.05). Serum adiponectin levels were higher in non-diabetic subjects but there was no significant correlation between adiponectin and alanine aminotransferase in both groups of subjects. The data suggest that low serum adiponectin level may not be a suitable marker for impaired liver function in diabetic patients.
- Published
- 2006